These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25770856)

  • 1. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
    Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
    Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
    Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
    J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.
    Hughes MM; Carballedo A; McLoughlin DM; Amico F; Harkin A; Frodl T; Connor TJ
    Brain Behav Immun; 2012 Aug; 26(6):979-87. PubMed ID: 22683764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
    Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
    Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.
    Savitz J; Dantzer R; Meier TB; Wurfel BE; Victor TA; McIntosh SA; Ford BN; Morris HM; Bodurka J; Teague TK; Drevets WC
    Psychoneuroendocrinology; 2015 Dec; 62():54-8. PubMed ID: 26232650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does escitalopram reduce neurotoxicity in major depression?
    Halaris A; Myint AM; Savant V; Meresh E; Lim E; Guillemin G; Hoppensteadt D; Fareed J; Sinacore J
    J Psychiatr Res; 2015; 66-67():118-26. PubMed ID: 26009299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder.
    Savitz J; Drevets WC; Wurfel BE; Ford BN; Bellgowan PS; Victor TA; Bodurka J; Teague TK; Dantzer R
    Brain Behav Immun; 2015 May; 46():55-9. PubMed ID: 25686798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery.
    Dahl J; Ormstad H; Aass HC; Malt UF; Bendz LT; Sandvik L; Brundin L; Andreassen OA
    Psychoneuroendocrinology; 2014 Jul; 45():77-86. PubMed ID: 24845179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
    Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
    Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of the kynurenine pathway in adolescent depression with melancholic features.
    Gabbay V; Klein RG; Katz Y; Mendoza S; Guttman LE; Alonso CM; Babb JS; Hirsch GS; Liebes L
    J Child Psychol Psychiatry; 2010 Aug; 51(8):935-43. PubMed ID: 20406333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of electroconvulsive therapy (ECT) on serum tryptophan metabolites.
    Aarsland TI; Leskauskaite I; Midttun Ø; Ulvik A; Ueland PM; Oltedal L; Erchinger VJ; Oedegaard KJ; Haavik J; Kessler U
    Brain Stimul; 2019; 12(5):1135-1142. PubMed ID: 31176607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.
    Cathomas F; Guetter K; Seifritz E; Klaus F; Kaiser S
    Sci Rep; 2021 May; 11(1):9992. PubMed ID: 33976271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder.
    Öztürk M; Yalın Sapmaz Ş; Kandemir H; Taneli F; Aydemir Ö
    Int J Clin Pract; 2021 Apr; 75(4):e13739. PubMed ID: 32997876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.